A Phase 2, Open-Label, Multiple Dose Study to Evaluate the Pharmacodynamic Effects, Safety, and Tolerability of a study drug for Oral Suspension in Children and Adolescents (2 to < 18) with Chronic Kidney Disease has been approved at 5 sites in Georgia. AmeRuss will be cooperating with another multinational CRO as a part...more
Category Archives: Uncategorized
AmeRuss is launching a phase III multinational study in prepubertal children with growth hormone deficiency (GHD). As part of a global team, AmeRuss will be responsible for initiating 7 sites in Georgia, Armenia, and Belarus. In these 3 sovereignties, AmeRuss will provide full service support for the study conduct....more
San Diego, CA, July 25, 2013BIOCOM is the largest regional life science association in the world, representing more than 550 member companies in Southern California. The association focuses on initiatives that positively influence the region’s biotechnology and medical device community. AmeRuss Clinical Trials, LLC is a proud member participant of this event. Thought leaders from...
The DIA (Drug Information Association) brought together a community of professionals at all levels and across all disciplines in the discovery, development, and life cycle management of medical products. The theme resonating from this year’s event was global cooperation and innovation. While these terms are often bantered about, it was truly evident this year. The inevitable...more